Fibroblast Growth Factor 21 is an Early Predictor of Acute ‐on‐Chronic Liver Failure in Critically Ill Cirrhotic Patients

Conclusion: This study demonstrates that FGF21 levels are of specific diagnostic value regarding presence and development of ACLF in patients admitted to intensive care unit for acute decompensation of liver cirrhosis. Further studies are warranted to address pathophysiological and possible therapeutic implications. This article is protected by copyright. All rights reserved.

Source: Liver Transplantation - February 24, 2018 Category: Transplant Surgery Authors: Astrid Ruiz ‐Margáin, Alessandra Pohlmann, Patrick Ryan, Robert Schierwagen, Luis A. Chi‐Cervera, Christian Jansen, Osvely Mendez‐Guerrero, Nayelli C. Flores‐García, Jennifer Lehmann, Aldo Torre, Ricardo Ulises Macías‐Rodríguez, Jonel Trebic Tags: Original Article Source Type: research